 |
 |

C-Reactive Protein and Risk of Colon Cancer
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Dr Erlinger and colleagues1 reported that C-reactive protein (CRP) levels were associated with risk of colon cancer. We have suggested that CRP is not merely a nonspecific marker of inflammation but has several important proinflammatory effects.2-3 In particular, CRP may activate endothelial cells, monocytes and smooth muscle cells, induce expression of adhesion molecules,2 chemoactractants,3 tissue factor, and activate the NF- B pathway.4 Although we are not aware of any studies on the effect of CRP on cancer cells or on epithelial cells of the gastrointestinal tract, expression of adhesion molecules is important for cancer invasion and activation of the NF- B pathway may have important oncogenic effects.5
Thus, it is possible that direct effects of CRP may contribute to its association with colon cancer. Statins, used as cholesterol-lowering drugs, may also reduce CRP and it would be interesting to know whether these drugs can reduce the incidence . . . [Full Text of this Article]
Vincenzo Pasceri, MD, PhD
vpasceri@hotmail.com Department of Cardiovascular Science San Filippo Neri Hospital
Giovanni Cammarota, MD
Department of Gastroenterology Catholic University Rome, Italy
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
C-Reactive Protein and Risk of Colon Cancer
Moutasim H. Al-Shaer
JAMA. 2004;291(23):2819.
EXTRACT
| FULL TEXT
C-Reactive Protein and Risk of Colon CancerReply
Thomas P. Erlinger, Elizabeth Platz, Kathy J. Helzlsouer, and Nader Rifai
JAMA. 2004;291(23):2819.
EXTRACT
| FULL TEXT
C-Reactive Protein and the Risk of Incident Colorectal Cancer
Thomas P. Erlinger, Elizabeth A. Platz, Nader Rifai, and Kathy J. Helzlsouer
JAMA. 2004;291(5):585-590.
ABSTRACT
| FULL TEXT
|